Developing effective vaccines: Cues from natural infection

被引:10
|
作者
Bhurani, Vishakha [1 ]
Mohankrishnan, Aditi [1 ]
Morrot, Alexandre [2 ,3 ]
Dalai, Sarat Kumar [1 ]
机构
[1] Nirma Univ, Inst Sci, Ahmadabad, Gujarat, India
[2] Univ Fed Rio de Janeiro, Fac Med, Rio De Janeiro, Brazil
[3] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, Brazil
关键词
Goals of vaccination; memory; natural infection; sub-unit vaccines; vaccines; T-CELL MEMORY; DENDRITIC CELLS; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; ANTIVIRAL IMMUNITY; VIRAL-INFECTION; VIRUS-INFECTION; CUTTING EDGE; YELLOW-FEVER; RECOMBINANT;
D O I
10.1080/08830185.2018.1471479
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The ultimate goal of any vaccine is to generate a heterogeneous and stable pool of memory lymphocytes. Vaccine are designed with the hope to generate antigen specific long-lived T cell responses, as it may be the case in natural infection; however, inducing such response by sub-unit vaccine has been a challenge. Although significant progress has been made, there is lot of scope for designing novel vaccine strategies by taking cues from the natural infection. This review focuses upon the roadblocks and the possible ways to overcome them leading to developing effective vaccines. Here we propose that mimicking the natural course of infection as well as the inclusion of non-target antigens in vaccine formulations might generate heterogeneous pool of memory T cells to ensure long-lived protection.
引用
收藏
页码:249 / 265
页数:17
相关论文
共 50 条
  • [1] Engineering synthetic vaccines using cues from natural immunity
    Darrell J. Irvine
    Melody A. Swartz
    Gregory L. Szeto
    [J]. Nature Materials, 2013, 12 : 978 - 990
  • [2] Engineering synthetic vaccines using cues from natural immunity
    Irvine, Darrell J.
    Swartz, Melody A.
    Szeto, Gregory L.
    [J]. NATURE MATERIALS, 2013, 12 (11) : 978 - 990
  • [3] Developing effective cancer vaccines
    Baxevanis, Constantin N.
    Perez, Sonia A.
    Papamichail, Michael
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S364 - S365
  • [4] Developing effective delivery systems for Chlamydia vaccines
    Igietseme, JU
    Eko, FO
    He, Q
    Bandea, C
    Black, CM
    [J]. CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2004, 6 (02) : 182 - 194
  • [5] Biological challenges to effective vaccines in the developing world
    Grassly, Nicholas C.
    Kang, Gagandeep
    Kannpmann, Beate
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2015, 370 (1671)
  • [6] Developing effective vaccines using IsoPlexis' highly
    不详
    [J]. SCIENTIST, 2021, 35 (02): : 39 - 39
  • [7] Broadening the approaches to developing more effective vaccines
    Babiuk, LA
    [J]. VACCINE, 1999, 17 (13-14) : 1587 - 1595
  • [8] BVD vaccines effective against transplacental infection
    Maillard, R
    [J]. POINT VETERINAIRE, 2006, 37 (266): : 81 - 81
  • [9] Developing effective tumor vaccines: Basis, challenges and perspectives
    Xu Q.
    Chen W.
    [J]. Frontiers of Medicine in China, 2007, 1 (1): : 11 - 19
  • [10] Developing effective cancer vaccines: design and monitoring are critical
    Armstrong, A
    Dermime, S
    [J]. BRITISH JOURNAL OF CANCER, 2001, 84 (11) : 1433 - 1436